2009
DOI: 10.1007/s00066-009-1008-x
|View full text |Cite
|
Sign up to set email alerts
|

Late Toxicity in Children Undergoing Hematopoietic Stem Cell Transplantation with TBI-containing Conditioning Regimens for Hematological Malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
29
0
1

Year Published

2010
2010
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(35 citation statements)
references
References 20 publications
(7 reference statements)
5
29
0
1
Order By: Relevance
“…In pediatric patients, especially high rates of late sequelae following TBI have been observed in studies with long median follow-up times of over 3 years [23,29]. Consistent with our data, hypothyroidism was observed in 12% of pediatric patients after a median FU of 3 years.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…In pediatric patients, especially high rates of late sequelae following TBI have been observed in studies with long median follow-up times of over 3 years [23,29]. Consistent with our data, hypothyroidism was observed in 12% of pediatric patients after a median FU of 3 years.…”
Section: Discussionsupporting
confidence: 80%
“…In the 1980s, dose rates were reduced resulting in a further decrease in late effects, especially cataractogenesis, renal toxicity, and interstitial pneumonitis [1,7,16] . Nevertheless, severe long-term sequelae, especially the induction of secondary malignancy, hormonal dysregulation, reproductive insufficiency, as well as growth retardation and the development of osteochondromas in pediatric patients remained an issue [15,21,23,29].…”
Section: Introductionmentioning
confidence: 99%
“…Heinzelmann et al [4] recently reported results from the German Registry for Stem Cell Transplantation (DSRT) with a comprehensive overview about role and indications for TBI. Beside its efficacy in the different treatment schedules, patients surviving TBI are known to be at risk to develop a broad variety of late side effects [1,3,5,10,12,14]. Although patient survival is still the major concern in patients undergoing TBI [4], the knowledge of late effects of this treatment approach is important for patient information and comparison of different treatment strategies.…”
Section: Introductionmentioning
confidence: 99%
“…As compared to autologous HSCT, the allogeneic stem cell source provides a pluripotent progenitor pool free of contaminated tumor cells and includes T cells capable of promoting the graft-versus-lymphoma (GVL) effect as part of an alloreactive mechanism [44,84]. In this context, total-body irradiation (TBI) plays a key role in the conditioning regimen prior to allogeneic HSCT [23,31,60,63,71] in order to eradicate malignant clonogenic cells and to achieve a sufficient immunosuppression [12]. The first series of successful allogeneic transplantations in patients with relapsed/chemorefractory FL was performed by van Besien et al mainly using a TBI-based conventional myeloablative conditioning protocol [82].…”
Section: First-line Treatment Strategies In Advanced Stages Iii/ivmentioning
confidence: 99%